Navigation Links
An effective drug for lung cancer

According to a new study, a drug combination has the potential to double the life expectancy of patients with asbestos-related lung cancer called Mesothelioma. Mesothelioma is a cancer of the cells that make up the lining// around the outside of the lungs and inside of the ribs or around the abdominal organs. It differs from other types of lung cancers in that it is caused by exposure to asbestos, rather than by smoking.

The condition affects five times more men than women and most commonly occurs in men between 50 and 80 years old. Doctors say this cancer is very difficult to treat. People diagnosed with the disease generally only survive for six to eight months.

Researchers at Newcastle University in the United Kingdom conducted a clinical trial to determine if the anticancer drug combination of pemetrexed and carboplatin was safe in patients with Mesothelioma. Twenty-seven patients were treated with five different doses of the drugs.

The study found that not only was the drug safe, but about one-third of the patients responded to the drug combination. On average, patients who were given the drug combination survived as long as 12 to 14 months. A few cases, patients survived for three years or more. Researchers also report 80 percent of the patients noticed an improvement in symptoms, usually after only 2 treatments.

Doctors call this study an important development in the treatment of Mesothelioma. The clinical trial showed an improvement in survival and symptoms for the first time in patients with this disease. A multinational trial is now underway to study this treatment further.


'"/>




Page: 1

Related medicine news :

1. Morning after pill effective up to five days after having unprotected sex
2. Distraction therapy found very effective in postoperative patients
3. TELITHROMYCIN - the proven effective new drug for cap
4. Digital mammography proves effective
5. Treatment for pre-menstrual syndrome is ineffective
6. Cost-effective antibiotics for sinusitis treatment
7. An effective way to treat angina
8. Fluoride proves effective against fractures
9. Meningitis C vaccine a cost-effective success
10. Naltrexone effective for drinking problems
11. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... VA (PRWEB) , ... July 24, 2017 , ... ... Managers, **Presented by FDAnews and MSceppa Consulting **, Aug. 22-23, 2017 – Arlington, ... on Friday, July 28. , Increased FDA scrutiny and growing demands to track ...
(Date:7/24/2017)... ... July 24, 2017 , ... Advanced ... Avenue, Bellmore, New York, (516) 784-5858. The office opened earlier this summer and ... Lori Friedman and Fruma Leah Wiederman. , Advanced Dermatology, P.C. founder and ...
(Date:7/24/2017)... , ... July 24, 2017 , ... “A Short Walk ... to the Mailbox” is the creation of published author, Ed Clark. Ed Clark ... Methodist, and Christian Reformed churches as a minister of music and worship leader for ...
(Date:7/23/2017)... ... 2017 , ... Three experts will be interviewed on Facebook ... & Exhibition, to be held in Denver, CO on July 30-August 3, 2017. ... visit the AAPM Facebook page to watch three speakers present their information and ...
(Date:7/23/2017)... CA (PRWEB) , ... July 23, 2017 , ... ... indicating women who underwent brief bursts of high-intensity, weight-bearing activity equivalent to a medium-paced ... health. , “As an orthopaedic surgeon who specializes in total spine care, I understand ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... MINNEAPOLIS , July 5, 2017 Pace Analytical, a company of ... announcing today that they have acquired ESC Lab Sciences, further solidifying their position ... the United States . ... Steve Vanderboom- President and CEO of Pace Analytical ... of ESC Lab Sciences out of Mt Juliet, TN , ...
(Date:6/30/2017)... Md. , June 30, 2017 In ... since the start of May, at least ten diagnostic ... include private investments, public offerings and a loan facility.  ... million to almost $80 million.  Kalorama Information provides a ... of its Diagnostics Knowledge Center. ...
(Date:6/27/2017)... TEL AVIV, Israel , June 27, 2017 /PRNewswire/ ... a specialty clinical-stage pharmaceutical company specializing in the development ... ring The Nasdaq Stock Market Opening Bell in ... 28, 2017 in honor of its initial public offering ... Nasdaq Capital Market in March 2017. Dr. ...
Breaking Medicine Technology: